SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001100412-17-000003
Filing Date
2017-02-09
Accepted
2017-02-09 08:11:28
Documents
62
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12311610-q.htm 10-Q 1214965
2 EXHIBIT 31.1 a12312016ex311.htm EX-31.1 14784
3 EXHIBIT 31.2 a12312016ex312.htm EX-31.2 14052
4 EXHIBIT 32.1 a12312016ex321.htm EX-32.1 11773
  Complete submission text file 0001100412-17-000003.txt   6924483

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arry-20161231.xml EX-101.INS 1536330
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arry-20161231.xsd EX-101.SCH 48453
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arry-20161231_cal.xml EX-101.CAL 68778
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arry-20161231_def.xml EX-101.DEF 311659
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arry-20161231_lab.xml EX-101.LAB 684065
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arry-20161231_pre.xml EX-101.PRE 431946
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-16633 | Film No.: 17584568
SIC: 2834 Pharmaceutical Preparations